Vulnerability in Fresenius-Kabi Pharmahelp
CVE-2022-45611
An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.
EPSS: 0.009 (57.4th percentile) — read the EPSS interpretation.
CVSS v3 metric
CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.
Affected products
- Fresenius-kabi Pharmahelp
- Fresenius-kabi Pharmahelp_firmware — versions 5.1.759.0
- N/a — versions n/a
Weakness classification (CWE)
References
- cve@mitre.org (Product)
- cve@mitre.org
- cve@mitre.org
Frequently asked questions
- What is CVE-2022-45611?
- CVE-2022-45611 is a critical-severity vulnerability in Fresenius-Kabi Pharmahelp, classified under Insufficiently Protected Credentials. CVSS score: 9.8/10. Published 2023-08-22.
- How severe is CVE-2022-45611?
- Critical severity. CVSS v3 base score is 9.8 out of 10.